Danhong Injection combined with t-PA attenuates cerebral ischemia/reperfusion injury and reduces hemorrhagic transformation: association with NF-κB/MMPs signaling
Journal of Pharmacy and Pharmacology · 01.10.2026 · 78 (10)
DOI: 10.1093/jpp/rgag129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 29.10.2026. Verfasst von Jinghui Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacy Department, Jinhua Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Jinhua 321017, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Tissue Plasminogen Activator, Reperfusion Injury, NF-kappa B. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Zhejiang Provincial Science and Technology Project of Traditional Chinese Medicine, Research Project of Zhejiang Chinese Medical University.
Abstract (Originalsprache)
Objectives
Ischemic stroke, caused by cerebral arterial thrombosis and interrupted blood supply, is a leading cause of brain dysfunction. Tissue plasminogen activator (t-PA) is the standard thrombolytic agent but is limited by hemorrhagic transformation (HT) and blood–brain barrier (BBB) damage. This study explored the beneficial effects of Danhong Injection (DHI, a Traditional Chinese Medicine) as an adjuvant combined with t-PA for the treatment of ischemic stroke.
Methods
Based on cell viability assays, optimal concentrations were 20 μl/ml DHI + 20 μg/ml t-PA. In vitro (mouse brain microvascular endothelial cell, OGD/R model) and in vivo (MCAO rat model) experiments were conducted to assess relevant parameters. Key findings In vitro, the combination improved cell morphology, reduced apoptosis, and downregulated phosphorylated NF-κB p65, MMP-2, MMP-9, and hypoxia-inducible factor-1α expression. In vivo, DHI + t-PA decreased P-Selectin, 6-keto-PGF1a, TXA2, PAI-1, MMP-2, and MMP-9 levels, alleviated cerebral infarction and HT, and enhanced neurological recovery.
Conclusions
These protective effects were accompanied by downregulation of the NF-κB/MMPs pathway, suggesting a plausible correlation linked to BBB-related protective phenotypes. Our findings provide preliminary evidence supporting DHI as a promising adjuvant to optimize t-PA-based stroke therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pharmacy Department, Jinhua Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Jinhua 321017, China.
- School of Life Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
- Department of Traditional Chinese Medicine Outpatient, Zhejiang Chinese Medical University, Hangzhou 310053, China.
ORCID-Profile: Bin Zhang, Yuyan Zhang, Shan Xu
Förderung
- Zhejiang Provincial Science and Technology Project of Traditional Chinese Medicine
- Research Project of Zhejiang Chinese Medical University
Zitieren
APA
Zhang, J., Shan, C., Yu, Z., Shi, R., Ye, C., Zhang, B., Zhang, Y., & Xu, S. (2026). Danhong Injection combined with t-PA attenuates cerebral ischemia/reperfusion injury and reduces hemorrhagic transformation: association with NF-κB/MMPs signaling. Journal of Pharmacy and Pharmacology, 78(10). https://doi.org/10.1093/jpp/rgag129
Vancouver
Zhang J, Shan C, Yu Z, Shi R, Ye C, Zhang B, et al. Danhong Injection combined with t-PA attenuates cerebral ischemia/reperfusion injury and reduces hemorrhagic transformation: association with NF-κB/MMPs signaling. Journal of Pharmacy and Pharmacology. 2026;78(10). doi:10.1093/jpp/rgag129
BibTeX
@article{Zhang2026,
author = {Zhang, Jinghui and Shan, Chuchu and Yu, Zebin and Shi, Rui and Ye, Changyi and Zhang, Bin and Zhang, Yuyan and Xu, Shan},
title = {Danhong Injection combined with t-PA attenuates cerebral ischemia/reperfusion injury and reduces hemorrhagic transformation: association with NF-κB/MMPs signaling},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
volume = {78},
number = {10},
doi = {10.1093/jpp/rgag129}
}
EUVIMED